| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 07/01/2010 | US20100168152 Fat regulation |
| 07/01/2010 | US20100168139 Inhibitors of human phosphatidylinositol 3-kinase delta |
| 07/01/2010 | US20100168134 Pyridyl piperidine orexin receptor antagonists |
| 07/01/2010 | US20100168129 Drugs with anticholestatic activity |
| 07/01/2010 | US20100168125 Indolizines and aza-analog derivatives thereof as cns active compounds |
| 07/01/2010 | US20100168110 Novel Compounds |
| 07/01/2010 | US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders |
| 07/01/2010 | US20100168105 Spirocyclopropyl Piperidine Derivatives |
| 07/01/2010 | US20100168103 Diaryl piperidine compounds as calcium channel blockers |
| 07/01/2010 | US20100168102 Amide Derivatives as Kinase Inhibitors |
| 07/01/2010 | US20100168101 Oxindole hydrazide modulators of protein tyrosine phosphatases (ptps) |
| 07/01/2010 | US20100168094 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/01/2010 | US20100168083 Adamantane derivatives for the treatment of the metabolic syndrome |
| 07/01/2010 | US20100168080 Novel compounds useful as cc chemokine receptor ligands |
| 07/01/2010 | US20100168075 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions |
| 07/01/2010 | US20100168070 Compounds for the treatment of alzheimer's disease |
| 07/01/2010 | US20100168068 Mao-b inhibitors useful for treating obesity |
| 07/01/2010 | US20100168062 Quinoxaline Derivatives as Tyrosine Kinase Activity Inhibitors |
| 07/01/2010 | US20100168061 Method for preparing enzymatically highly branched-amylose and amylopectin cluster |
| 07/01/2010 | US20100168056 Dietary fiber formulation and method of administration |
| 07/01/2010 | US20100168054 Functionalized Beta 1,6 Glucosamine Disaccharides and Process for Their Preparation |
| 07/01/2010 | US20100168053 Oral delivery system for methylcobalamin to treat disorders |
| 07/01/2010 | US20100168051 Altered Mitochondrial Activity in Diseases Resulting From Oxidative Stress |
| 07/01/2010 | US20100168039 Novel 2-Azetidinone Derivatives As Cholesterol Absorption Inhibitors For The Treatment Of Hyperlipidaemic Conditions |
| 07/01/2010 | US20100168032 Smart Pro-Drugs of Serine Protease Inhibitors |
| 07/01/2010 | US20100168021 Urocortin proteins and uses thereof |
| 07/01/2010 | US20100168014 Screening method |
| 07/01/2010 | US20100168011 Pharmaceutical Formulations and Methods for Making the Same |
| 07/01/2010 | US20100168005 Pyridin-3-yl derivatives as immunomodulating agents |
| 07/01/2010 | US20100167990 Pharmaceutical Formulations Comprising an Insulin Derivative |
| 07/01/2010 | US20100167989 Isopropoxyphenylmethyl inhibitors of sglt2 |
| 07/01/2010 | US20100167988 Ethoxyphenylmethyl inhibitors of sglt2 |
| 07/01/2010 | US20100167986 Cholesteryl Ester Transfer Protein Inhibitors |
| 07/01/2010 | US20100167985 Oral insulin composition and methods of making and using thereof |
| 07/01/2010 | US20100166899 Hypoglycemic compositon containing acacia bark derivative |
| 07/01/2010 | US20100166874 Technology for Preparation of Macromolecular Microspheres |
| 07/01/2010 | US20100166857 Pharmaceutical dosage forms and methods of manufacturing same |
| 07/01/2010 | US20100166826 Biodegradable intravaginal devices for delivery of therapeutics |
| 07/01/2010 | US20100166778 Toll-Like Receptor 3 Antagonists |
| 07/01/2010 | US20100166762 Method of treating a pathological syndrome |
| 07/01/2010 | US20100166733 Mcp-1 splice variants and methods of using same |
| 07/01/2010 | US20100166728 Novel Highly Functional Enzyme Having Modified Substrate-Specificity |
| 07/01/2010 | US20100166718 Large scale pancreatic islet purification |
| 07/01/2010 | US20100166675 Pharmaceutical Composition for the Treatment of Type 1-Diabetes |
| 07/01/2010 | US20100166674 Transdermal delivery rate control using amorphous pharmaceutical compositions |
| 07/01/2010 | CA2748250A1 Indanyl compounds |
| 07/01/2010 | CA2748249A1 Cyclic amine compounds |
| 07/01/2010 | CA2748124A1 Ppar agonist compositions and methods of use |
| 07/01/2010 | CA2747809A1 Bicyclic heterocycle derivatives and methods of use thereof |
| 07/01/2010 | CA2747807A1 Pyrimidine derivatives and methods of use thereof |
| 07/01/2010 | CA2747230A1 Oligosaccharide-protein conjugates |
| 07/01/2010 | CA2746966A1 Maintenance fluid for animals |
| 07/01/2010 | CA2746561A1 Dihydropyridone amides as p2x7 modulators |
| 07/01/2010 | CA2745952A1 Dihydropyridone amides as p2x7 modulators |
| 06/30/2010 | EP2202240A1 Compound |
| 06/30/2010 | EP2202216A1 Spiro-ring compound and use thereof for medical purposes |
| 06/30/2010 | EP2201959A2 Use of IL-12 and IL-12 antagonists for the manufacture of a pharmaceutical composition for the treatment of autoimmune diseases |
| 06/30/2010 | EP2201948A1 Maintenance fluid for animals |
| 06/30/2010 | EP2201011A2 Novel compounds having indazole frameworks, methods for preparing the same and pharmaceutical composition comprising the same |
| 06/30/2010 | EP2201010A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 06/30/2010 | EP2200987A1 Arylsulfonylaminomethylphosphonic acid derivatives, the preparation thereof and the use thereof as pharmaceutical compositions |
| 06/30/2010 | EP2200628A2 Disease treatment via antimicrobial peptides or their inhibitors |
| 06/30/2010 | EP2200609A1 Compounds for the treatment of metabolic disorders |
| 06/30/2010 | EP2200607A1 Compounds that modulate intracellular calcium |
| 06/30/2010 | EP2021336B1 Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 06/30/2010 | EP1599480B1 Substituted hexahydropyrazino(1,2-a)pyrimidin-4,7-dion derivatives, method for the production and use thereof as medicaments |
| 06/30/2010 | EP1558572B1 Novel compounds and their use as prar-modulators |
| 06/30/2010 | EP1516881B1 Composition and method for modulating dendritic Cell-T cell interaction |
| 06/30/2010 | EP1476435B1 Novel pyridin- and pyrimidin-derivatives |
| 06/30/2010 | EP1465616B1 Treatment of statin side effects using uridine derivatives |
| 06/30/2010 | CN101765433A An anti-diabetic extract of rooibos |
| 06/30/2010 | CN101765426A Amino-acid-containing medicinal granular preparation highly easy to take |
| 06/30/2010 | CN101765425A The use of benzamide derivatives for the treatment of cns disorders |
| 06/30/2010 | CN101762673A Method for detection of illegally added chemical in traditional Chinese medicine preparation |
| 06/30/2010 | CN101760446A Method for preparing monocyte type stem cell and application |
| 06/30/2010 | CN101759801A Separation and purification method of novel soybean trypsin inhibitor |
| 06/30/2010 | CN101759754A Synthetic method of beta-Sitosterol Nicotinate |
| 06/30/2010 | CN101759683A Preparation method of hydrindene amide compound, medical composition comprising hydrindene amide compound and application thereof as protein kinase inhibitor |
| 06/30/2010 | CN101759682A Synthetic method of alpha-lipoic acid |
| 06/30/2010 | CN101757627A Combined drug and drug combination for treating diabetes |
| 06/30/2010 | CN101757599A Medicinal granules comprising brown sugar, Colla corii Asini, Cornu cervi Pantotrichum, ginseng, clove, costus root, red jujube and tea |
| 06/30/2010 | CN101757551A Blood fat lowering compound oral powder |
| 06/30/2010 | CN101757543A Nutritive oral liquid for building up health and preparation method thereof |
| 06/30/2010 | CN101757530A Plaster for treating diabetes mellitus of spleen deficiency type |
| 06/30/2010 | CN101757508A Traditional Chinese medicine preparation for treating diabetes mellitus |
| 06/30/2010 | CN101757499A Traditional Chinese medicine composite for treating impaired glucose tolerance |
| 06/30/2010 | CN101757497A Prescription for reducing fat, removing heat from liver, protecting liver and smoothening microcirculation and preparation method |
| 06/30/2010 | CN101757495A Traditional Chinese medicine for antidiarrhea and antidehydration |
| 06/30/2010 | CN101757482A Middle diabetes eliminating pill |
| 06/30/2010 | CN101757471A Hyperglycemic composition |
| 06/30/2010 | CN101757470A Blood fat lowering composition |
| 06/30/2010 | CN101757448A Pure Chinese medicine sterilization anti-inflammatary suspension liniment and preparation method thereof |
| 06/30/2010 | CN101757435A Traditional Chinese medicine for treating diabetes mellitus |
| 06/30/2010 | CN101757421A Traditional Chinese medicine composite for treating obesity |
| 06/30/2010 | CN101757400A Traditional Chinese medicine preparation for treating diabetes |
| 06/30/2010 | CN101757394A Traditional Chinese medicine preparation for treating heart disease |
| 06/30/2010 | CN101757391A Medicine composition for treating cardio-cerebral-vascular diseases and preparation method and application thereof |
| 06/30/2010 | CN101757316A Orally administrated medicine for Chinese traditional treatment of hepatolenticular degeneration |
| 06/30/2010 | CN101757301A Prescription for reduction of three highs, softening of blood vessel and protection of heart and brain cell and preparation method thereof |
| 06/30/2010 | CN101757253A Traditional Chinese medicine and Western medicine composition containing gliquidone |